Stanford University
Showing 30,081-30,100 of 35,021 Results
-
Azusa Terasaki
Postdoctoral Scholar, Pathology
BioAzusa Terasaki, MD, PhD, is a Postdoctoral scholar in the Department of Pathology at Stanford University School of Medicine. Her research focuses on tumor immunology and cancer metabolism, with a particular interest in mitochondrial transfer between cancer and immune cells and its role in immune suppression and metastasis.
Dr. Terasaki received her medical degree and PhD in Japan, where she completed her surgical training and is a board-certified surgeon with additional certifications as a breast specialist and in cancer therapy. During her clinical career, she developed a strong interest in translational research that bridges fundamental discoveries and patient care.
Her current work investigates how cancer cells reprogram immune cells through organelle transfer, integrating imaging, flow cytometry, and multi-omic approaches to uncover novel mechanisms of tumor–immune interaction. Her goal is to identify new therapeutic targets and biomarkers to improve cancer treatment outcomes. -
Maximilian Terhalle
Visiting Scholar,
Affiliate, FinanceBioDr Maximilian Terhalle is currently a visiting scholar at Stanford University's Hoover Institution, an appointment that follows his attendance of Hoover's International Seminar in 2023. In his home country, he serves as an instructor at the Hamburg-based Defence Academy (Germany).
Thinking "fast and slow" about the art of making strategic choices, about strategies and strategic culture lies at the heart of his research, shaped as it is by real-world practice. A former strategic adviser himself (UK MoD), Maximilian aims at weaving together notions of common sense, insights from neuroscience, political psychology, historical knowledge, as well as notions of leadership into his understanding of strategic mindsets, grand strategy and national security.
At Stanford/Hoover, Maximilian looks forward to pushing the boundaries of his own understanding of the latest round in the "struggle for power" which the West is undergoing in world politics.
Previously, he taught and/or conducted research at Columbia's SIPA , Yale, LSE, Oxford, and King's College London, among others. His most recent book is "The Responsibility to Defend: Re-thinking Germany's Strategic Culture" (IISS 2021, w. Bastian Giegerich).
He obtained his Master's degrees from London and Bonn Universities (1998, 2005), his PhD from Bonn University (GER, 2006) and his Habilitation (higher doctorate) from Potsdam University (GER, 2016). Also, Maximilian is a reserve officer, currently holding the rank of a lieutenant colonel (reconn.). He is married with four amazing children. -
Nele Marie Terveen
Affiliate, Geballe Laboratory for Advanced Materials
BioNele Marie Terveen is an Assistant Professor (Lecturer) in Innovation & Strategy at the University of Auckland, New Zealand, and is affiliated with Stanford in Professor Yi Cui's lab.
In her research, she looks at complex problems, serendipity, and innovation as well as ideation processes, specifically in the sustainability domain. She loves to explore novel phenomena through inductive and ethnographic study designs.
She aims to drive transformation at the intersection of science and practice, was invited to speak in the European Parliament for the Green Pioneers, is involved as a Fellow in the Think Tank of the Club of Rome Germany, and serves as a jury member of the Green Startup Program of the Deutsche Bundesstiftung Umwelt, as well as an ambassador of the Economy for the Common Good. -
Stefano Testa
Instructor, Medicine - Oncology
BioDr. Testa is a medical oncologist and physician-scientist specializing in cellular therapy and the care of patients with soft tissue and bone sarcomas. He earned his medical degree from the University of Naples Federico II in Naples, Italy. He subsequently moved to the United States and conducted research in the laboratory of Dr. Ronald Levy at Stanford University, where he studied intratumoral vaccination strategies and mRNA delivery platforms designed to target B cells and T cells in vivo. He completed his internal medicine residency at Stanford University, followed by a fellowship in hematology and oncology at Beth Israel Deaconess Medical Center. Dr. Testa’s research focuses on identifying targets for adoptive T-cell therapies in solid tumors, particularly soft tissue and bone sarcomas, and on novel synthetic biology approaches to enhance the effectiveness of T-cell therapies against solid tumors.
